Old Web
English
Sign In
Acemap
>
Paper
>
HMO-4 Immunogenicity to second anti-TNF therapy (IMSAT): implications for sequencing of biologic therapy
HMO-4 Immunogenicity to second anti-TNF therapy (IMSAT): implications for sequencing of biologic therapy
2021
Neil Chanchlani
Simeng Lin
Amanda Thomas
Ben Hamilton
Rachel Nice
Desmond Chee
Nicholas A. Kennedy
James R Goodhand
Tariq Ahmad
Keywords:
Immunology
Immunogenicity
Medicine
Anti-TNF therapy
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]